Patents by Inventor Max G. Reese

Max G. Reese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4317921
    Abstract: The chloramine T procedure is employed to provide radioiodinated T.sub.3 and radioiodinated T.sub.4 from T.sub.3 and T.sub.4, respectively, at specified pHs and mole ratios to provide for long shelf life. T.sub.3 is also radioiodinated to high specific activity radioiodinated T.sub.4, and purified after a specified waiting period to remove radioactive non-antigenic contaminants and thereby provide a long shelf life.
    Type: Grant
    Filed: April 25, 1979
    Date of Patent: March 2, 1982
    Assignee: Becton Dickinson & Company
    Inventors: Max G. Reese, Richard H. Hales
  • Patent number: 4279885
    Abstract: An analyte, such as an antigen, is initially contacted with a receptor (antibody) bound to a solid support, in the absence of tracer, followed by removal of unbound analyte and contacting with tracer. By separately contacting the receptor with analyte and tracer, sensitivity is increased.
    Type: Grant
    Filed: May 19, 1978
    Date of Patent: July 21, 1981
    Assignee: Becton Dickinson & Company
    Inventors: Max G. Reese, Dennis K. Ransom, LaVell R. Johnson
  • Patent number: 4238471
    Abstract: Automated assay for qualitative determination of thyroid hormone binding capacity of a serum sample in which serum and T.sub.3 tracer are caused to flow through a chamber containing a T.sub.3 binder supported on a solid support. The amount of T.sub.3 tracer which passes through the chamber, and the amount of T.sub.3 tracer bound to the binder in the chamber are determined to thereby determine the percent of bound T.sub.3 tracer. Such percent is then compared with the percent of T.sub.3 tracer bound in a referenced sample to qualitatively determine the T.sub.3 binding capacity of the serum sample.
    Type: Grant
    Filed: July 12, 1978
    Date of Patent: December 9, 1980
    Assignee: Becton, Dickinson and Company
    Inventors: Max G. Reese, LaVell R. Johnson
  • Patent number: 4200625
    Abstract: In an automated assay employing a reusable immobilized binder in a flow-through chamber, the binder is supported on a cotton support preferably mercerized absorbent cotton. Such cotton support prevents plugging when using free serum or plasma samples, and in addition, does not compress, has good flow properties, is easily handled, has low non-specific binding of proteins and steroids and is stable.
    Type: Grant
    Filed: July 12, 1978
    Date of Patent: April 29, 1980
    Assignee: Becton, Dickinson and Company
    Inventor: Max G. Reese
  • Patent number: 4192858
    Abstract: The chloramine T procedure is employed to provide radioiodinated T.sub.3 and radioiodinated T.sub.4 from T.sub.3 and T.sub.4, respectively, at specified pHs and mole ratios to provide for long shelf life. T.sub.3 is also radioiodinated to high specific activity radioiodinated T.sub.4, and purified after a specified waiting period to remove radioactive non-antigenic contaminants and thereby provide a long shelf life.
    Type: Grant
    Filed: February 21, 1978
    Date of Patent: March 11, 1980
    Assignee: Becton, Dickinson and Company
    Inventors: Max G. Reese, Richard H. Hales
  • Patent number: 4108976
    Abstract: Automated radioimmunoassay directly from serum, for those antigens present in serum in relatively small amounts, is accomplished by use of an immobilized immunoadsorbent having an excess of antibodies, specific to the antigen, covalently bonded to a particulate substrate. The serum is diluted and preincubated in the presence of a radioactive labelled antigen and an antibody specific to the antigen. The preincubated mixture is flowed through the immobilized immunoadsorbent and the labelled and unlabelled antigen not bound to the antibody in preincubation are bound to the immobilized immunoadsorbent while the labelled and unlabelled antigen bound to the antibody during preincubation flow through the immunoadsorbent. An eluting solution is flowed through the immunoadsorbent to release the antigens bound thereto for reuse of the immunoadsorbent.
    Type: Grant
    Filed: March 4, 1977
    Date of Patent: August 22, 1978
    Assignee: Becton, Dickinson and Company
    Inventor: Max G. Reese